The guy who bought in March did so for reasons totally unrelated to ISC's management's decision to pay OTC Journal to hype the company. The guy who bought at $2.60 likely did so either on watching the percentage gains triggered by OTC Journal or read the OTC Journal hype himself. The buyer in March did so on pure speculation without any evidence justifying his buy. Don't confuse the issue which only masks the unethical behavior of management in hiring OTC Journal.